Stockscreener 앱 받기
0.68
9.05%
0.029
전일 마감가:
$0.651
열려 있는:
$0.66
하루 거래량:
12,700
Relative Volume:
0.47
시가총액:
$4.48M
수익:
$1.10M
순이익/손실:
$-10.96M
주가수익비율:
-0.3316
EPS:
-2.0506
순현금흐름:
$-7.01M
1주 성능:
+15.81%
1개월 성능:
+29.07%
6개월 성능:
-41.81%
1년 성능:
+11.69%
1일 변동 폭
$0.66
$0.7001
1주일 범위
$0.58
$0.7001
52주 변동 폭
$0.48
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
명칭
Matinas Biopharma Holdings Inc
전화
908-443-1860
주소
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.7001 | 4.17M | 1.10M | -10.96M | -7.01M | -2.0506 |
VRTX
Vertex Pharmaceuticals Inc
|
428.60 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
718.43 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.45 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
304.43 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
312.07 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | 재개 | Piper Sandler | Overweight |
| 2020-01-27 | 개시 | Piper Sandler | Overweight |
| 2020-01-24 | 개시 | SunTrust | Buy |
| 2020-01-23 | 개시 | SunTrust | Buy |
| 2020-01-09 | 개시 | Aegis Capital | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
모두보기
Matinas Biopharma Holdings Inc 주식(MTNB)의 최신 뉴스
MSN Money - MSN
Net current asset value per share of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
Operating cash flow per share of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
Matinas BioPharma Holdings, Inc. (MTNB) - Minichart
Sell Signal: Will Matinas BioPharma Holdings Inc benefit from government policy2026 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Aug Setups: Can Matinas BioPharma Holdings Inc generate free cash flow2026 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
Analyst Upgrade: Can Matinas BioPharma Holdings Inc ride the EV waveJobs Report & Real-Time Volume Analysis - baoquankhu1.vn
Aug Wrap: What are the risks of holding Matinas BioPharma Holdings Inc2026 Earnings Surprises & High Accuracy Trade Alerts - baoquankhu1.vn
SHPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Matinas BioPharma Receives NYSE American Non-Compliance Notice Due to Stockholders’ Equity and Ongoing Losses 1 - Minichart
SHPH PE Ratio & Valuation, Is SHPH Overvalued - Intellectia AI
Matinas BioPharma Faces NYSE Compliance Issues - Intellectia AI
Heritage Signs & Displays Completes JD Lewis Center Transformative Branding Project in Raleigh, NC - Weekly Voice
Matinas BioPharma Holdings, Inc. Notifies NYSE American of Non-Compliance with Continued Listing Standards - Quiver Quantitative
Matinas BioPharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Matinas BioPharma (NYSE American: MTNB) faces NYSE non-compliance and cure deadline - Stock Titan
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - ChartMill
MAT2203 stakes rise as Matinas BioPharma (NYSE: MTNB) slashes staff, seeks partner - Stock Titan
Gains Recap: What are the future prospects of Matinas BioPharma Holdings IncEarnings Performance Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Germany Stocks: Research Stocks from Germany Stock Market - GuruFocus
TOTDY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
DBSM.SI Should I Buy - Intellectia AI
Volume Recap: Will Matinas BioPharma Holdings Inc outperform tech stocks2026 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
BHAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MTNB PE Ratio & Valuation, Is MTNB Overvalued - Intellectia AI
Aug Update: Is Matinas BioPharma Holdings Inc a stock for growth or value investors2026 Pullback Review & Safe Entry Momentum Stock Tips - baoquankhu1.vn
ES=F PE Ratio & Valuation, Is ES=F Overvalued - Intellectia AI
Performance Recap: What are the future prospects of Matinas BioPharma Holdings Inc2026 Momentum & Breakout Confirmation Trade Signals - baoquankhu1.vn
Volume Recap: Whats the beta of Matinas BioPharma Holdings Inc stockTrade Exit Report & Low Risk High Win Rate Picks - baoquankhu1.vn
MTNB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Dow Update: Can Matinas BioPharma Holdings Inc keep up with sector leaders2026 Technicals & Fast Entry and Exit Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
002044.SZ Forecast — Price Prediction for 2026. Should I Buy 002044.SZ? - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CLF Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving PremarketC3.ai - Benzinga
Gainers Report: How does ATHPRC correlate with NasdaqSwing Trade & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Can Matinas BioPharma Holdings Inc. ride the EV waveJuly 2025 Review & Risk Managed Trade Strategies - Mfd.ru
Is Matinas BioPharma Holdings Inc. a stock for growth or value investorsJuly 2025 Recap & Safe Capital Growth Tips - mfd.ru
Why Matinas BioPharma Holdings Inc. (6LJ0) stock is favored by hedge fundsWeekly Stock Report & High Accuracy Investment Signals - mfd.ru
Can Matinas Biopharma Holdings Inc. stock survive global slowdownWeekly Investment Report & Consistent Growth Stock Picks - mfd.ru
Entry Recap: Is Matinas BioPharma Holdings Inc exposed to currency risksJuly 2025 Catalysts & Weekly Breakout Watchlists - baoquankhu1.vn
What are the future prospects of Matinas BioPharma Holdings Inc.Trade Risk Summary & Smart Allocation Stock Tips - mfd.ru
What is Matinas BioPharma Holdings Inc. s P E ratio telling us2025 Biggest Moves & Safe Entry Zone Identification - mfd.ru
Can Matinas BioPharma Holdings Inc. stock outperform in 2025 bull market2025 Key Lessons & Weekly High Return Forecasts - mfd.ru
Merger Talk: Can Matinas BioPharma Holdings Inc ride the EV waveTrade Performance Summary & High Conviction Trade Alerts - baoquankhu1.vn
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO By Investing.com - Investing.com Nigeria
Matinas BioPharma CEO Named Interim Chief Financial Officer - The Globe and Mail
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO - Investing.com
Matinas Biopharma Holdings Inc (MTNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
3.01%
자본화:
|
볼륨(24시간):